MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
78.65%
Quick Ratio
44.84%
Debt to Asset Ratio
98.58%
Unit: Thousand (K) dollars
Assets Breakdown
    • Less accumulated depreciation an...
    • Inventories
    • Cash
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Series d redeemable convertible ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
1,089
933
993
966
Accounts receivable, net
959
791
723
1,015
Inventories
1,685
1,773
1,514
1,591
Prepaid expenses and other current assets
187
316
181
162
Total current assets
3,920
3,813
3,411
3,734
Non-current inventories
256
226
229
239
Property and equipment, gross
2,524
2,635
2,614
2,622
Less accumulated depreciation and amortization
2,365
2,466
2,454
2,430
Property and equipment, net
159
169
160
192
Intangible assets, net
515
633
644
661
Right-of-use assets
175
261
344
425
Deposits and other assets
31
31
31
31
Total assets
5,056
5,133
4,819
5,282
Accounts payable
310
437
168
265
Accrued liabilities
969
842
428
452
Operating lease liabilities, current
199
297
393
383
Advances
250
250
250
250
Related party note payable
3,256
3,223
3,340
3,305
Total current liabilities
4,984
5,049
4,579
4,655
Operating lease liabilities, net of current portion
0
0
-
103
Total liabilities
4,984
5,049
4,579
4,758
Series d redeemable convertible preferred stock, 0.001 par value 50 shares authorized 43 shares issued and outstanding liquidation preference of 4,300 at june 30, 2026 and december 31, 2025
4,300
4,300
4,300
4,300
Non-redeemable convertible preferred stock, 0.001 par value 10,004,310 and 10,004,310 shares authorized 5,254,310 and 5,254,310 shares issued and outstanding liquidation preference of 9,834 and 9,826 at june 30, 2026 and december 31, 2025, respectively
5
5
5
5
Common stock, 0.001 par value 120,000,000 shares authorized 8,004,389 shares issued and outstanding at june 30, 2026 and december 31, 2025
8
8
8
8
Additional paid-in capital
107,153
107,094
107,030
106,966
Accumulated deficit
-111,394
-111,323
-111,103
-110,755
Total stockholders' deficit
-4,228
-4,216
-4,060
-3,776
Total liabilities, redeemable convertible preferred stock and stockholders' deficit
5,056
5,133
4,819
5,282
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventories$1,685K (8.71%↑ Y/Y)Cash$1,089K (18.37%↑ Y/Y)Accounts receivable, net$959K (-12.90%↓ Y/Y)Prepaid expenses andother current assets$187K (-30.48%↓ Y/Y)Property and equipment,gross$2,524K (-3.70%↓ Y/Y)Total current assets$3,920K (2.08%↑ Y/Y)Intangible assets, net$515K (-24.38%↓ Y/Y)Non-current inventories$256K (-3.76%↓ Y/Y)Right-of-use assets$175K (-65.28%↓ Y/Y)Property and equipment,net$159K (-29.33%↓ Y/Y)Deposits and other assets$31K (0.00%↑ Y/Y)Less accumulateddepreciation and...$2,365K (-1.29%↓ Y/Y)Total assets$5,056K (-8.85%↓ Y/Y)Accumulated deficit-$111,394K (-0.53%↓ Y/Y)Total liabilities,redeemable convertible...$5,056K (-8.85%↓ Y/Y)Total stockholders'deficit-$4,228K (-8.52%↓ Y/Y)Additional paid-in capital$107,153K (0.23%↑ Y/Y)Common stock, 0.001 parvalue 120,000,000...$8K (0.00%↑ Y/Y)Non-redeemable convertiblepreferred stock, 0.001 par...$5K (0.00%↑ Y/Y)Total liabilities$4,984K (-3.09%↓ Y/Y)Series d redeemableconvertible preferred...$4,300K (0.00%↑ Y/Y)Total currentliabilities$4,984K (0.91%↑ Y/Y)Related party notepayable$3,256K (-0.43%↓ Y/Y)Accrued liabilities$969K (48.85%↑ Y/Y)Accounts payable$310K (-21.91%↓ Y/Y)Advances$250K (0.00%↑ Y/Y)Operating leaseliabilities, current$199K (-46.36%↓ Y/Y)

International Stem Cell CORP (ISCO)

International Stem Cell CORP (ISCO)